TOKYO & MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--SanBio Company Limited (hereafter, “the Company”) hereby announces that it entered into a business partnership agreement with D&P Bioinnovations, Inc.
LECO’s Citius™ LC-HRT High Resolution Time-of-Flight Mass Spectrometer offers an inherent advantage over traditional Q-TOF instrumentation with its unique MSc2 fragmentation technology. This novel ...
Under the partnership agreement, SanBio will grant D&P a non-exclusive, non-transferable license to use MSC2 for the development and commercialization of the latter’s regenerative esophageal implant.
LECO’s Citius™ LC-HRT High Resolution Time-of-Flight Mass Spectrometer offers an inherent advantage over traditional Q-TOF instrumentation with its unique MSc2 fragmentation technology. This novel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results